Jennifer Kreick co-author of the American Health Law Association’s article on regulatory due diligence for digital health transactions – Healthcare


To print this article, all you need to do is be registered or log in to

Jennifer Kreick, a health and life sciences partner at Haynes Boone, collaborated on an article for the American Health Law Association with a team of attorneys from several law firms. Read an excerpt below:

The digital health technology market is booming, generating a wealth of investment opportunities and an ever-increasing volume of digital health transactions. Given the complex regulatory landscape surrounding these transactions, proper due diligence is essential to protect investors. Digital health encompasses a wide range of technologies, including telehealth, mobile health apps, diagnostic tools and technologies, electronic health records (EHRs), wearable devices, remote patient monitoring and many more. others. The variety of digital health technologies can make due diligence difficult due to the various healthcare regulations that can be implicated by different technologies. This briefing outlines some of the potential health care regulatory considerations for a digital health transaction and includes tools, such as a sample due diligence checklist, for such transactions.

Excerpt from a briefing by the American Health Law Association. To read the full article, click here.

Originally published by the American Health Law Association

The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

POPULAR ARTICLES ON: US Food, Drugs, Healthcare, Life Sciences

7 Things to Know About the New AdvaMed Code Updates

Sheppard Mullin Richter & Hampton

On March 18, 2022, AdvaMed announced updates to the Code of Ethics for Interactions with Healthcare Professionals (“Code”), a voluntary code that provides medical technology companies…


About Author

Comments are closed.